Oral squamous cell carcinoma (OSCC) is the most malignant tumor of the head and neck [1]. Despite considerable advances in treatment, about 50% of patients with locally advanced disease relapse with local or distant disease progression [2,3]. Investigating specific molecular markers related to the capacity for tumor invasion and treatment sensitivity could provide new insights for the identification of innovative treatments.
from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2wwQv4q
via IFTTT
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
▼
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,